Washington, DC 20006-5349
HELPLINE
As part of its patient support services, the Mesothelioma Applied Research Foundation provides an array of support groups. Some are administered over the phone while…
The Meso Foundation announced today the addition of its new communications manager. Tobias Rodriguez has joined the organization and in this role he will work…
A phase 3 randomized clinical trial looking into the efficacy of combination chemotherapy with immunotherapy is now open in the United States and Australia. How…
Since 2008, the Department of Defense has funded mesothelioma research through its Congressionally Directed Medical Research Program – more specifically, through the Peer Reviewed Cancer…
The challenges of treating mesothelioma are well known to this community of patients, caregivers, bereaved, and the physicians who treat them. Particularly, researchers have been…
The Mesothelioma Applied Research Foundation is pleased to announce the addition of seven new members to its science advisory board (SAB). Madhavi Ganapathiraju, PhD – University of Pittsburgh Jonathan…
A Phase 3 trial in relapsed mesothelioma patients showed a significant improvement in overall survival and progression-free survival when patients were treated with nivolumab. Nivolumab…
The Mesothelioma Applied Research Foundation is pleased to announce the addition of five new members to the organization’s board of directors. Jessica Blackford-Cleeton – Springfield, Illinois Cheryl Bruner, Esq. – Louisville, Kentucky Randy Krocka – Sheet…
This MesoTV panel of four mesothelioma patients and one caregiver discuss survivors’ guilt and other issues affecting mesothelioma survivors. Chris DeSantis Heather Von St James…
Today, the Mesothelioma Applied Research Foundation, among 130 organizations, cancer centers, and other institutions, sent a letter to President Joseph R. Biden, key members of…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
